Asia Pacific

Overview | Technology Development | Contact

Technology Development

The BioVenture Centre in Singapore accesses and develops technologies through research collaborations, options and licensing. Substantial alignment with BD strategy is required, but the technologies need not be fully developed. BD partnership may include completion of proof of concept technology development, establishment of clinical utility, registration and manufacture of new products. BD is particularly interested in the following technologies.

• Materials to stabilize biologic therapies
• Diagnostics to enable improved outcomes for diabetes, cancer and infectious diseases
• Animal-free media, factors, ECMs, for improved expansion or differentiation, of adult stem cells
• Novel reagents for cell analysis